Just Breathe: Clinical Updates in the Treatment of Asthma and COPD - ppt download
Long‑acting muscarinic antagonist and long‑acting β2‑agonist therapy to optimize chronic obstructive pulmonary disease prior to lung cancer surgery
The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis - Kazuya Tanimura,
drugs-respiratory1.ppt
New developments in inhaled therapy | Practice Nursing
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Table 1 from Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. | Semantic Scholar
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table2-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")
PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar
Bronchodilators: Beta 2-agonists and muscarinic antagonists | Osmosis
Journal of the COPD Foundation Self-reported COPD Medication Use and Adherence in the COPD Foundation Patient-Powered Research N
New COPD Medications - AARC
Follow-up treatment of COPD patients. Abbreviations: laMa, long-acting... | Download Scientific Diagram
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
Long‐acting muscarinic antagonists and small airways in asthma: Which link? - Cazzola - 2021 - Allergy - Wiley Online Library
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis | BMC Pulmonary Medicine | Full Text
SABA (short acting beta agonist) inhalers Aerosol InhalersGeneric Component No of doses Cost/ device Dosing directions Ventolin evohalerSalbutamol 100mcg/dose200£ ppt download
Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium
Algorithm showing use of inhaled therapies. FEV 1 , forced expiratory... | Download Scientific Diagram
Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram
Muscarinic Antagonist - an overview | ScienceDirect Topics
Long-Acting Muscarinic Antagonists - LAMA (Anticholinergic) ... | GrepMed
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
